Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, July 20, 2024 | Back issues
Courthouse News Service Courthouse News Service


CHICAGO - Abbott, Solvay, GlaxoSmithKline and others pushed testosterone with false claims that it's a "cure for the male aging process," a pension fund claims in a RICO class action; click headline to see the defendants in Federal Court.

Here are the defendants: AbbVie, Abbott Laboratories, Abbott Products, Solvay America, Solvay Pharmaceuticals,; Solvay S.A., Unimed Pharmaceuticals, Besins Healthcare, Besins Healthcare SA, Auxilium Pharmaceuticals, GlaxoSmithKline, Oscient Pharmaceuticals, and Endo Pharmaceuticals. - allied services

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.